Sign in
Not yet recruitingNo phase

Spinal skin stimulation plus augmented reality training for pain and balance in diabetic neuropathy

Tests combined spinal stimulation and augmented reality training for pain and balance in diabetic neuropathy.

Key facts

Who runs it
Riphah International University
Where
Pakistan1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
tSCS and AR on Pain and Balance in Diabetic Peripheral Neuropathy
Status
Not yet recruiting
People taking part
36 people, planned
Started
15 Jun 2026
Expected to end
31 Jan 2027
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • transcutaneous spinal cord stimulation
  • Augmented Reality
Record updated
2 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with nerve pain from diabetic neuropathy (nerve damage caused by diabetes). It tests skin-surface spinal cord stimulation, augmented reality training, or both, for pain and balance.

Age
18 Years and older
Sex
All
Disease stage
Diabetic neuropathy with a score of 4 or more on the Douleur Neuropathique 4 Questionnaire, and pain of 4 or more on the Numeric Pain Rating Scale (NPRS).
Biomarker or test result
Vibration sense test: 6 Hz or more on a Neurothesiometer.

Main reasons for not taking part

  • Problems with memory or thinking (MOCA ≤ 26/30)
  • Metal implants in the skull
  • Having a shunt
  • Skin allergy

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • More than or equals to 4 score on Douleur Neuropathique 4 Questionnaire
  • More than or equals to 6 Hz at Neurothesiometer
  • More than or equals to 4 score on the Numeric Pain Rating Scale (NPRS)

Who cannot take part

  • Metallic implants at skull
  • Skin allergy
  • Cognitively compromised (MOCA ≤ 26/30)
  • Shunting

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

tSCS and AR-based training have individually shown benefits in neuromotor rehabilitation; no study to date has evaluated their combined effects on pain, balance, lower-limb strength, retention, and vibration sense in diabetic neuropathy. The rationale for combining them lies in their complementary mechanisms: tSCS at 30 Hz activates large-diameter Aβ afferents, inhibiting nociceptive input, enhancing spinal excitability, and facilitating motor activation.

The 3 groups in the trial

  • Transcutaneous spinal cord stimulation and Augmented Reality GroupTreatment being tested

    Treatment: transcutaneous spinal cord stimulation and Augmented Reality

  • Augmented Reality GroupExisting treatment, for comparison

    Treatment: Augmented Reality

  • Transcutaneous spinal cord stimulation GroupExisting treatment, for comparison

    Treatment: transcutaneous spinal cord stimulation

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Combined Effects of Transcutaneous Spinal Cord Stimulation (tSCS) and Augmented Reality (AR) Training on Pain and Balance in Diabetic Neuropathy Patients.
Plain-language title
Spinal skin stimulation plus augmented reality training for pain and balance in diabetic neuropathyGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
2 June 2026